Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Eric Lipp et al.|The Lancet Oncology|2016Cited by 374
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Jason Fangusaro, Daniel Picard et al.|The Lancet Oncology|2015Cited by 182
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated MedulloblastomaManabu Natsumeda, Akiyoshi Kakita, Hiroaki Miyahara et al.|Journal of Neuropathology & Experimental Neurology|2020Cited by 7
PATH-46. NEURONAL DIFFERENTIATION IS INDUCED BY Gli3 IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMAManabu Natsumeda, Yukihiko Fujii, Hiroaki Miyahara et al.|Neuro-Oncology|2018Cited by 0